2012, Number 11
Three-in-one block for analgesia in patients with hip fracture
Language: Spanish
References: 51
Page: 1698-1706
PDF size: 184.04 Kb.
ABSTRACT
A therapeutic intervention was conducted in 81 older adults with hip fracture, who underwent emergency operation in "Dr. Ambros io Grillo Portuondo" Teaching Clinical Surgical Hospital of Santiago de Cuba, fr om January 2008 to January 2009 in order to determine the effectiveness of the 3-in-1 block for pain relief in the preoperative period. Patients were randomly assigned to two tr eatment groups: study gr oup (n=39) in whom 3-in-1 block with 0.5 % bupivacaine was ad ministered, and control group (n=42), which was treated intramuscularly with metamizole (600 mg every 8 hours). Using a visual analogical scale pain was measured at the beginning of the treatment, after 30 and 60 minutes, and every 4 hours to complete 12. A prevalence of 60-79 (51.2%) age group and female sex (58.0%) was found, as well as a reduction of the di sease at rest with both therapeutic procedures. Also, adequate pain relief was achieved in those that received 3-in-1 block, of them only 5.1% required rescue analge sia, so that this technique was effective to achieve the desired effect.REFERENCES
Nápoles Méndez D, Cutié León ER. Nuevo protocolo diagnóstico y terapéutico en la distocia de fase latente del trabajo de parto [tesis doctoral]. Santiago de Cuba: Hospital Provincial Ginecoobstétrico "Mariana Grajales Coello", 2008 [citado 17 Jul 2012]. Disponible en: http://tesis.repo.sld.cu/83/1/Danilo_Napoles.pdf
Curry AE, Vogel I, Drews C, Schended D, Skogstrand K, Flanders WD, et al. Midpregnancy maternal plasma levels of interluking 2, 6 and 12, tumor necrosis factoralpha, interferon-gamma and granulocyte macrophage colony-stimulating factor and spontaneous preterm de livery. Acta Obstet Gynecol. 2007; 86: 1103-10.
Romero R, Mazor M. Infección y trabajo de parto pretérmino. En: Trabajo de parto pretérmino. Cirugía Ginecológica. La Habana: Editorial Revolucionaria. 1988; 3: 537-65. 2. Gómez Mora R. Infección intrauterina y daño neurológico fetal. En: Cabero Roura L. Parto prematuro. Madrid: Editorial Médica Panamericana; 2004. p. 77-82. 3. Romero R, Sirtori M, Oyarzun E, Ávila C, Mazor M, Callahan R, et al. Infection and labor. V. Prevalence, microbiology and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am J Obstet Gynecol. 1989; 61: 817-24. 4. Gibbs RS. Premature rupture of the membranes. En: Danforth´s. Obstetrics and gynecology. 9 ed. México, DF: McGraw-Hill Interamericana; 2003. p. 281-97. 5. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol. 1998; 179(1):186-93. 6. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet. 2008;371 (9606):75-84. 7. Nápoles Méndez D, Cutié León ER. Nuevo protocolo diagnóstico y terapéutico en la distocia de fase latente del trabajo de parto [tesis doctoral]. Santiago de Cuba: Hospital Provincial Ginecoobstétrico "Mariana Grajales Coello", 2008 [citado 17 Jul 2012]. Disponible en: http://tesis.repo.sld.cu/83/1/Danilo_Napoles.pdf 8. Marcell Rodríguez L, González Ramírez VE. Relación de las citoquinas proinflamatorias con la corioamnionitis subclínica y el parto pretérmino. Rev Cubana Obstet Ginecol. 2011; 37(4): 562-76. 9. Machado J, Rocha L, Barrilari S, Pucci K, Reis M, Castro E, et al. Influence of maternal and fetal intercurrences on the different degrees of chorioamnionitis. Rev Bras Ginecol Obstet. 2012; 34(4): 153-57. 10. Rincón Ricote MI, Magdaleno Dans F, Sancha Naranjo M, Omeñaca Teres F, González González A. Corioamnionitis histológica y morbimortalidad neonatal: aproximación al síndrome de respuesta inflamatoria fetal. Rev Chil Ginecol Obstet. 2010; 75(3): 172-78. 11. Faneite P, Rivera C, Amato R, Faneite J. Corioamnionitis: Repercusión perinatal. Rev Obstet Ginecol Venezuela. 2010; 70(4): 233-9. 12. Correa AD, Motta BS, Reis D, Pinheiro D, Murta É, Cardoso JP, et al. Chorioamnionitis: case report and review. Rev Med Minas Gerais. 2009; 19(4 Supl 3): 53-7. 13. Argilagos Casasayas G, Arañó Piedra J, Pérez Reina M, Morando Flores D, Hierrezuelo Gonzales G. Impacto maternoperinatal de la corioamnionitis. MEDISAN. 2012 [citado 17 Jul 2012]; 16(1). Disponible en: http://bvs.sld.cu/revistas/san/vol_16_1_12/san07112.pdf 14. Curry AE, Vogel I, Drews C, Schended D, Skogstrand K, Flanders WD, et al. Midpregnancy maternal plasma levels of interluking 2, 6 and 12, tumor necrosis factoralpha, interferon-gamma and granulocyte macrophage colony-stimulating factor and spontaneous preterm de livery. Acta Obstet Gynecol. 2007; 86: 1103-10. 15. Jacobsson BO, Altonen R, Rantakokko L, Jalava K, Morken NH, Alonen A. Quantification of ureoplasmaurealyticun DNA in the amniotic fluid from patients in PTL an p PROM and its relation to inflammatory cytokine levels. Acta Obstet Gynecol. 2009; 88: 63-70. 16. Cunningham EG, Gant NF, Leveno kl, Gilstrap LC, Aut JC. Parto pretérmino. En: William's Obstetricia. La Habana: Editorial Ciencias Médicas; 2007. p. 592-621. 17. Buhimschi IA, Buhimschi CS. Proteomics of the amniotic fluid in assessment of the placenta – relevance for preterm birth. Placenta. 2008 [citado 2 Ago 2012]; 29. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362148/ 18. Castagnino JM. Proteómica y sus aplicaciones en medicina humana. Acta Bioquím Clin Latinoam. 2008 [citado 2 Ago 2012]; 42(2). Disponible en: http://www.scielo.org.ar/pdf/abcl/v42n2/v42n2a01.pdf 19. Zaragoza García E, Molina García FS, Carrillo Badillo MP, Garrote Fernández de Santos A, Calpena García A. Marcadores bioquímicos y determinantes genómicos y proteómicos del parto pretérmino [citado 2 Ago 2012]. Disponible en: http://www.hvn.es/servicios_asistenciales/ginecologia_y_obstetricia/ficheros/08marc adoresbioquimicosydeterminantesezaragoza.pdf 20.Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, et al. The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. BJOG. 2006; 113 (Suppl 3):118- 35.